GlassScriptPhysician profile
Mark J Pressman
NPI 1649230673
$9,526.56
in general payments reported to CMS, 2019-2025
26 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $495 · 2021: $1,125 · 2022: $2,416 · 2023: $2,058 · 2024: $632 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,217 · Travel and Lodging: $1,098 · Education: $77.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,216.59 |
| Travel and Lodging | $1,098.34 |
| Education | $77.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $1,357.79 | 2023 | Amistem, Gmk Efficiency |
| Seapearl East, INC | $1,326.07 | 2022-2024 | |
| Encore Medical, LP | $1,248.85 | 2019-2024 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $948.91 | 2019-2025 | Oxford, Rosa, G7 |
| Stryker Corporation | $877.29 | 2019-2025 | Gamma, Hydroset, Pangea |
| Medical Device Business Services, INC. | $683.91 | 2022 | |
| Pacira Therapeutics, INC. | $580.66 | 2019-2021 | |
| Depuy Synthes Sales INC. | $466.53 | 2019-2023 | Na |
| Ferring Pharmaceuticals INC. | $282.87 | 2019-2025 | Euflexxa |
| Smith+Nephew, INC. | $264.34 | 2022-2025 | Pico 14, Renasys Touch |
| Baxter Healthcare | $251.24 | 2023 | Floseal |
| Bioventus LLC | $187.48 | 2019-2025 | Durolane |
| Innovation Technologies INC | $150.90 | 2024 | Irrisept |
| Heraeus Medical, LLC. | $139.48 | 2021 | |
| Davol INC. | $127.06 | 2024 | Channel Drain |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $110.94 | 2022-2025 | Iovera, Zilretta |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Kci USA, INC. | $99.13 | 2023 | Prevena |
| Ossio INC | $90.13 | 2020 | |
| Next Science LLC | $68.74 | 2023 | Xperience, Blastx, Surgx |
| Fidia Pharma USA INC. | $58.59 | 2025 | Hymovis, Triluron |
| Acumed LLC | $35.04 | 2019 | |
| Dynasplint Systems INC. | $21.19 | 2025 | Dynasplint |
| Medtronic USA, INC. | $20.38 | 2019 | |
| Horizon Therapeutics Plc | $14.25 | 2021 | |
| Endo Pharmaceuticals INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pressman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.